BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25189222)

  • 21. Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis.
    Tang H; Huang T; Jing J; Shen H; Cui W
    Infection; 2009 Dec; 37(6):497-507. PubMed ID: 19826761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.
    Stocker M; Fontana M; El Helou S; Wegscheider K; Berger TM
    Neonatology; 2010; 97(2):165-74. PubMed ID: 19776651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.
    Daniels JM; Schoorl M; Snijders D; Knol DL; Lutter R; Jansen HM; Boersma WG
    Chest; 2010 Nov; 138(5):1108-15. PubMed ID: 20576731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
    Briel M; Schuetz P; Mueller B; Young J; Schild U; Nusbaumer C; Périat P; Bucher HC; Christ-Crain M
    Arch Intern Med; 2008 Oct; 168(18):2000-7; discussion 2007-8. PubMed ID: 18852401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Comparison of Procalcitonin Guidance Administer Antibiotics with Empiric Antibiotic Therapy in Critically Ill Patients Admitted in Intensive Care Unit.
    Najafi A; Khodadadian A; Sanatkar M; Shariat Moharari R; Etezadi F; Ahmadi A; Imani F; Khajavi MR
    Acta Med Iran; 2015; 53(9):562-7. PubMed ID: 26553084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD.
    Corti C; Fally M; Fabricius-Bjerre A; Mortensen K; Jensen BN; Andreassen HF; Porsbjerg C; Knudsen JD; Jensen JU
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1381-9. PubMed ID: 27382274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procalcitonin-guided antibiotic use in acute exacerbations of idiopathic pulmonary fibrosis.
    Ding J; Chen Z; Feng K
    Int J Med Sci; 2013; 10(7):903-7. PubMed ID: 23781136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission--a randomized trial.
    Kristoffersen KB; Søgaard OS; Wejse C; Black FT; Greve T; Tarp B; Storgaard M; Sodemann M
    Clin Microbiol Infect; 2009 May; 15(5):481-7. PubMed ID: 19416298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection.
    Burkhardt O; Ewig S; Haagen U; Giersdorf S; Hartmann O; Wegscheider K; Hummers-Pradier E; Welte T
    Eur Respir J; 2010 Sep; 36(3):601-7. PubMed ID: 20185423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
    Nobre V; Harbarth S; Graf JD; Rohner P; Pugin J
    Am J Respir Crit Care Med; 2008 Mar; 177(5):498-505. PubMed ID: 18096708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Value of serum procalcitonin for the guidance of antibiotic therapy in children with lower respiratory tract infection].
    Dai BQ; Yuan XT; Liu JM
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Dec; 17(12):1292-6. PubMed ID: 26695667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study.
    Schroeder S; Hochreiter M; Koehler T; Schweiger AM; Bein B; Keck FS; von Spiegel T
    Langenbecks Arch Surg; 2009 Mar; 394(2):221-6. PubMed ID: 19034493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
    Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
    Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procalcitonin, pyuria and proadrenomedullin in the management of urinary tract infections--'triple p in uti': study protocol for a randomized controlled trial.
    Drozdov D; Thomer A; Meili M; Schwarz S; Kouegbe RB; Regez K; Guglielmetti M; Schild U; Conca A; Schäfer P; Reutlinger B; Ottiger C; Buchkremer F; Litke A; Schuetz P; Huber A; Bürgi U; Fux CA; Bock A; Müller B; Albrich WC;
    Trials; 2013 Mar; 14():84. PubMed ID: 23522152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hospital Procalcitonin Testing and Antibiotic Treatment of Patients Admitted for Chronic Obstructive Pulmonary Disease Exacerbation.
    Lindenauer PK; Shieh MS; Stefan MS; Fisher KA; Haessler SD; Pekow PS; Rothberg MB; Krishnan JA; Walkey AJ
    Ann Am Thorac Soc; 2017 Dec; 14(12):1779-1785. PubMed ID: 28795838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis: A multicenter retrospective study.
    Maseda E; Suarez-de-la-Rica A; Anillo V; Tamayo E; García-Bernedo CA; Ramasco F; Villagran MJ; Maggi G; Gimenez MJ; Aguilar L; Granizo JJ; Buño A; Gilsanz F
    J Crit Care; 2015 Jun; 30(3):537-42. PubMed ID: 25600574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Procalcitonin is a good tool to guide duration of antibiotic therapy in patients with severe acute pancreatitis. A randomized prospective single-center controlled trial.
    Qu R; Ji Y; Ling Y; Ye CY; Yang SM; Liu YY; Yang RY; Luo YF; Guo Z
    Saudi Med J; 2012 Apr; 33(4):382-7. PubMed ID: 22485232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial.
    Manzano S; Bailey B; Girodias JB; Galetto-Lacour A; Cousineau J; Delvin E
    Am J Emerg Med; 2010 Jul; 28(6):647-53. PubMed ID: 20637377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.